ArticleOncotarget2014
A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabine.
Elisabeth Walsby et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
45 papers cite it
this papercites it
ArticleOncotarget2014
Elisabeth Walsby et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.